Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
2004 1
2015 1
2018 3
2019 2
2020 2
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Tumor oxygenation and cancer therapy-then and now.
Hughes VS, Wiggins JM, Siemann DW. Hughes VS, et al. Among authors: wiggins jm. Br J Radiol. 2019 Jan;92(1093):20170955. doi: 10.1259/bjr.20170955. Epub 2018 Mar 14. Br J Radiol. 2019. PMID: 29513032 Free PMC article. Review.
Cell-Free DNA in Dermatology Research.
Wiggins JM, Ali S, Polsky D. Wiggins JM, et al. J Invest Dermatol. 2022 Jun;142(6):1523-1528.e1. doi: 10.1016/j.jid.2022.02.021. J Invest Dermatol. 2022. PMID: 35598899 Free PMC article.
Stromal cells in breast cancer as a potential therapeutic target.
Dykes SS, Hughes VS, Wiggins JM, Fasanya HO, Tanaka M, Siemann D. Dykes SS, et al. Among authors: wiggins jm. Oncotarget. 2018 May 4;9(34):23761-23779. doi: 10.18632/oncotarget.25245. eCollection 2018 May 4. Oncotarget. 2018. PMID: 29805773 Free PMC article. Review.
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study.
Syeda MM, Wiggins JM, Corless BC, Long GV, Flaherty KT, Schadendorf D, Nathan PD, Robert C, Ribas A, Davies MA, Grob JJ, Gasal E, Squires M, Marker M, Garrett J, Brase JC, Polsky D. Syeda MM, et al. Among authors: wiggins jm. Lancet Oncol. 2021 Mar;22(3):370-380. doi: 10.1016/S1470-2045(20)30726-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587894 Free PMC article. Clinical Trial.
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.
Chang GA, Robinson E, Wiggins JM, Zhang Y, Tadepalli JS, Schafer CN, Darvishian F, Berman RS, Shapiro R, Shao Y, Osman I, Polsky D. Chang GA, et al. Among authors: wiggins jm. J Invest Dermatol. 2022 Oct;142(10):2733-2743.e9. doi: 10.1016/j.jid.2022.03.031. Epub 2022 Apr 22. J Invest Dermatol. 2022. PMID: 35469904 Free PMC article.
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors.
Chang GA, Wiggins JM, Corless BC, Syeda MM, Tadepalli JS, Blake S, Fleming N, Darvishian F, Pavlick A, Berman R, Shapiro R, Shao Y, Karlin-Neumann G, Spittle C, Osman I, Polsky D. Chang GA, et al. Among authors: wiggins jm. J Invest Dermatol. 2020 Aug;140(8):1609-1618.e7. doi: 10.1016/j.jid.2020.01.027. Epub 2020 Feb 20. J Invest Dermatol. 2020. PMID: 32087194 Free PMC article.
Tight Chk1 Levels Control Replication Cluster Activation in Xenopus.
Platel M, Goldar A, Wiggins JM, Barbosa P, Libeau P, Priam P, Narassimprakash H, Grodzenski X, Marheineke K. Platel M, et al. Among authors: wiggins jm. PLoS One. 2015 Jun 5;10(6):e0129090. doi: 10.1371/journal.pone.0129090. eCollection 2015. PLoS One. 2015. PMID: 26046346 Free PMC article.
14 results